The University of Chicago Header Logo

Connection

Jeffrey Hubbell to Animals

This is a "connection" page, showing publications Jeffrey Hubbell has written about Animals.
Connection Strength

3.004
  1. Engineered GM-CSF polarizes protumorigenic tumor-associated macrophages to an antitumorigenic phenotype and potently synergizes with IL-12 immunotherapy. J Immunother Cancer. 2024 Dec 22; 12(12).
    View in: PubMed
    Score: 0.061
  2. Blocking antibodies against integrin-a3, -aM, and -aMß2 de-differentiate myofibroblasts, and improve lung fibrosis and kidney fibrosis. Sci Rep. 2024 09 16; 14(1):21623.
    View in: PubMed
    Score: 0.060
  3. Injectable butyrate-prodrug micelles induce long-acting immune modulation and prevent autoimmune arthritis in mice. J Control Release. 2024 Aug; 372:281-294.
    View in: PubMed
    Score: 0.059
  4. Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia. Blood Adv. 2024 04 09; 8(7):1747-1759.
    View in: PubMed
    Score: 0.058
  5. A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice. Nat Biomed Eng. 2024 May; 8(5):611-627.
    View in: PubMed
    Score: 0.058
  6. Glycosylation-modified antigens as a tolerance-inducing vaccine platform prevent anaphylaxis in a pre-clinical model of food allergy. Cell Rep Med. 2024 01 16; 5(1):101346.
    View in: PubMed
    Score: 0.057
  7. Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses. Nat Biomed Eng. 2023 09; 7(9):1142-1155.
    View in: PubMed
    Score: 0.056
  8. Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker. Nat Biomed Eng. 2022 07; 6(7):819-829.
    View in: PubMed
    Score: 0.051
  9. Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant. Biomaterials. 2021 11; 278:121159.
    View in: PubMed
    Score: 0.049
  10. Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance. Front Immunol. 2021; 12:714842.
    View in: PubMed
    Score: 0.049
  11. Engineered bridge protein with dual affinity for bone morphogenetic protein-2 and collagen enhances bone regeneration for spinal fusion. Sci Adv. 2021 06; 7(24).
    View in: PubMed
    Score: 0.048
  12. Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin-10 in Murine Models. Arthritis Rheumatol. 2021 05; 73(5):769-778.
    View in: PubMed
    Score: 0.047
  13. Soluble N-Acetylgalactosamine-Modified Antigens Enhance Hepatocyte-Dependent Antigen Cross-Presentation and Result in Antigen-Specific CD8+ T Cell Tolerance Development. Front Immunol. 2021; 12:555095.
    View in: PubMed
    Score: 0.047
  14. Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction. Sci Immunol. 2021 02 26; 6(56).
    View in: PubMed
    Score: 0.047
  15. Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis. Nat Biomed Eng. 2021 05; 5(5):387-398.
    View in: PubMed
    Score: 0.046
  16. Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours. Nat Biomed Eng. 2020 05; 4(5):531-543.
    View in: PubMed
    Score: 0.044
  17. Conferring extracellular matrix affinity enhances local therapeutic efficacy of anti-TNF-a antibody in a murine model of rheumatoid arthritis. Arthritis Res Ther. 2019 12 23; 21(1):298.
    View in: PubMed
    Score: 0.043
  18. Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Sci Adv. 2019 12; 5(12):eaay1357.
    View in: PubMed
    Score: 0.043
  19. Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies. Sci Adv. 2019 11; 5(11):eaay1971.
    View in: PubMed
    Score: 0.043
  20. Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy. Sci Adv. 2019 08; 5(8):eaaw6081.
    View in: PubMed
    Score: 0.042
  21. Targeted antibody and cytokine cancer immunotherapies through collagen affinity. Sci Transl Med. 2019 04 10; 11(487).
    View in: PubMed
    Score: 0.041
  22. Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity. Nat Mater. 2019 02; 18(2):175-185.
    View in: PubMed
    Score: 0.040
  23. Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity. Mol Cancer Ther. 2018 11; 17(11):2399-2411.
    View in: PubMed
    Score: 0.039
  24. Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing. Nat Commun. 2018 06 04; 9(1):2163.
    View in: PubMed
    Score: 0.039
  25. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses. J Allergy Clin Immunol. 2017 Nov; 140(5):1339-1350.
    View in: PubMed
    Score: 0.036
  26. Difference in suitable mechanical properties of three-dimensional, synthetic scaffolds for self-renewing mouse embryonic stem cells of different genetic backgrounds. J Biomed Mater Res B Appl Biomater. 2017 Nov; 105(8):2261-2268.
    View in: PubMed
    Score: 0.034
  27. Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses. Vaccine. 2016 05 05; 34(21):2453-2459.
    View in: PubMed
    Score: 0.033
  28. TLR-3 stimulation improves anti-tumor immunity elicited by dendritic cell exosome-based vaccines in a murine model of melanoma. Sci Rep. 2015 Dec 03; 5:17622.
    View in: PubMed
    Score: 0.033
  29. Engineering growth factors for regenerative medicine applications. Acta Biomater. 2016 Jan; 30:1-12.
    View in: PubMed
    Score: 0.032
  30. Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens. Sci Rep. 2015 Oct 29; 5:15907.
    View in: PubMed
    Score: 0.032
  31. Crystalline Oligo(ethylene sulfide) Domains Define Highly Stable Supramolecular Block Copolymer Assemblies. ACS Nano. 2015 Jul 28; 9(7):6872-81.
    View in: PubMed
    Score: 0.032
  32. Engineering antigen-specific immunological tolerance. Curr Opin Immunol. 2015 Aug; 35:80-8.
    View in: PubMed
    Score: 0.032
  33. Prescription for a pharmacyte. Sci Transl Med. 2015 Jun 10; 7(291):291fs23.
    View in: PubMed
    Score: 0.031
  34. The TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccine. Sci Rep. 2015 Feb 24; 5:8569.
    View in: PubMed
    Score: 0.031
  35. Overcoming immunological barriers in regenerative medicine. Nat Biotechnol. 2014 Aug; 32(8):786-94.
    View in: PubMed
    Score: 0.030
  36. Device design and materials optimization of conformal coating for islets of Langerhans. Proc Natl Acad Sci U S A. 2014 Jul 22; 111(29):10514-9.
    View in: PubMed
    Score: 0.029
  37. Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164. Proc Natl Acad Sci U S A. 2014 May 13; 111(19):6952-7.
    View in: PubMed
    Score: 0.029
  38. Translating materials design to the clinic. Nat Mater. 2013 Nov; 12(11):963-6.
    View in: PubMed
    Score: 0.028
  39. Tissue, cell and engineering. Curr Opin Biotechnol. 2013 Oct; 24(5):827-9.
    View in: PubMed
    Score: 0.028
  40. Extracellular matrix in angiogenesis: dynamic structures with translational potential. Exp Dermatol. 2011 Jul; 20(7):605-13.
    View in: PubMed
    Score: 0.024
  41. SPARC-derived protease substrates to enhance the plasmin sensitivity of molecularly engineered PEG hydrogels. Biomaterials. 2011 Feb; 32(5):1301-10.
    View in: PubMed
    Score: 0.023
  42. Drug development: Longer-lived proteins. Nature. 2010 Oct 28; 467(7319):1051-2.
    View in: PubMed
    Score: 0.023
  43. Improving protein pharmacokinetics by engineering erythrocyte affinity. Mol Pharm. 2010 Dec 06; 7(6):2141-7.
    View in: PubMed
    Score: 0.023
  44. Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-2. Biomaterials. 2010 Oct; 31(30):7836-45.
    View in: PubMed
    Score: 0.022
  45. In vitro uptake of amphiphilic, hydrogel nanoparticles by J774A.1 cells. J Biomed Mater Res A. 2010 Jun 15; 93(4):1557-65.
    View in: PubMed
    Score: 0.022
  46. Materials engineering for immunomodulation. Nature. 2009 Nov 26; 462(7272):449-60.
    View in: PubMed
    Score: 0.021
  47. Functionalization of polysulfide nanoparticles and their performance as circulating carriers. Biomaterials. 2008 Apr; 29(12):1958-66.
    View in: PubMed
    Score: 0.019
  48. Lymphatic drainage function and its immunological implications: from dendritic cell homing to vaccine design. Semin Immunol. 2008 Apr; 20(2):147-56.
    View in: PubMed
    Score: 0.019
  49. Non-viral gene delivery: multifunctional polyplexes as locally triggerable nonviral vectors. Gene Ther. 2006 Oct; 13(19):1371-2.
    View in: PubMed
    Score: 0.017
  50. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005 Jan; 23(1):47-55.
    View in: PubMed
    Score: 0.015
  51. Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats. J Small Anim Pract. 2005 Jan; 46(1):17-21.
    View in: PubMed
    Score: 0.015
  52. Off-the-Shelf Implant to Bridge a Urethral Defect: Multicenter 8-Year Journey From Bench to Bed. Urology. 2025 Feb; 196:294-299.
    View in: PubMed
    Score: 0.015
  53. Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2. Microvasc Res. 2004 Nov; 68(3):169-78.
    View in: PubMed
    Score: 0.015
  54. Tissue and cell engineering. Curr Opin Biotechnol. 2004 Oct; 15(5):381-2.
    View in: PubMed
    Score: 0.015
  55. Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2. Biomaterials. 2004 Jul; 25(16):3245-57.
    View in: PubMed
    Score: 0.015
  56. N-terminal alpha-dystroglycan binds to different extracellular matrix molecules expressed in regenerating peripheral nerves in a protein-mediated manner and promotes neurite extension of PC12 cells. Mol Cell Neurosci. 2003 Dec; 24(4):1062-73.
    View in: PubMed
    Score: 0.014
  57. Materials as morphogenetic guides in tissue engineering. Curr Opin Biotechnol. 2003 Oct; 14(5):551-8.
    View in: PubMed
    Score: 0.014
  58. Bioadhesive polymer semiconductors and transistors for intimate biointerfaces. Science. 2023 08 11; 381(6658):686-693.
    View in: PubMed
    Score: 0.014
  59. Membrane-localized neoantigens predict the efficacy of cancer immunotherapy. Cell Rep Med. 2023 08 15; 4(8):101145.
    View in: PubMed
    Score: 0.014
  60. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci U S A. 2003 Apr 29; 100(9):5413-8.
    View in: PubMed
    Score: 0.014
  61. Chemisorbed poly(propylene sulphide)-based copolymers resist biomolecular interactions. Nat Mater. 2003 Apr; 2(4):259-64.
    View in: PubMed
    Score: 0.014
  62. Treatment of peanut allergy and colitis in mice via the intestinal release of butyrate from polymeric micelles. Nat Biomed Eng. 2023 Jan; 7(1):38-55.
    View in: PubMed
    Score: 0.013
  63. Immunoengineering approaches for cytokine therapy. Am J Physiol Cell Physiol. 2021 08 01; 321(2):C369-C383.
    View in: PubMed
    Score: 0.012
  64. Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J. 2001 May; 15(7):1300-2.
    View in: PubMed
    Score: 0.012
  65. Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas. Sci Adv. 2021 03; 7(13).
    View in: PubMed
    Score: 0.012
  66. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release. 2000 Apr 03; 65(3):389-402.
    View in: PubMed
    Score: 0.011
  67. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nat Biotechnol. 2000 Apr; 18(4):415-9.
    View in: PubMed
    Score: 0.011
  68. Three-dimensional migration of neurites is mediated by adhesion site density and affinity. J Biol Chem. 2000 Mar 10; 275(10):6813-8.
    View in: PubMed
    Score: 0.011
  69. Intraarterial protein delivery via intimally-adherent bilayer hydrogels. J Control Release. 2000 Feb 14; 64(1-3):205-15.
    View in: PubMed
    Score: 0.011
  70. Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering. FASEB J. 1999 Dec; 13(15):2214-24.
    View in: PubMed
    Score: 0.011
  71. Growth factors with enhanced syndecan binding generate tonic signalling and promote tissue healing. Nat Biomed Eng. 2020 04; 4(4):463-475.
    View in: PubMed
    Score: 0.011
  72. Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes. Nat Biomed Eng. 2019 10; 3(10):817-829.
    View in: PubMed
    Score: 0.010
  73. The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing. Blood. 2019 06 13; 133(24):2559-2569.
    View in: PubMed
    Score: 0.010
  74. A bioactive injectable bulking material; a potential therapeutic approach for stress urinary incontinence. Biomaterials. 2019 06; 206:41-48.
    View in: PubMed
    Score: 0.010
  75. Biotechnology. A new-for-old urinary bladder. Nature. 1999 Mar 18; 398(6724):198-9.
    View in: PubMed
    Score: 0.010
  76. Combination of Synthetic Long Peptides and XCL1 Fusion Proteins Results in Superior Tumor Control. Front Immunol. 2019; 10:294.
    View in: PubMed
    Score: 0.010
  77. Quantitative intrinsic auto-cathodoluminescence can resolve spectral signatures of tissue-isolated collagen extracellular matrix. Commun Biol. 2019; 2:69.
    View in: PubMed
    Score: 0.010
  78. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bioconjug Chem. 1999 Jan-Feb; 10(1):75-81.
    View in: PubMed
    Score: 0.010
  79. Reduction of fibrous adhesion formation by a copolymer possessing an affinity for anionic surfaces. J Biomed Mater Res. 1998 Oct; 42(1):55-65.
    View in: PubMed
    Score: 0.010
  80. Murine macrophage behavior on peptide-grafted polyethyleneglycol-containing networks. Biotechnol Bioeng. 1998 Jul 05; 59(1):2-9.
    View in: PubMed
    Score: 0.010
  81. Fiber density of collagen grafts impacts rabbit urethral regeneration. Sci Rep. 2018 07 03; 8(1):10057.
    View in: PubMed
    Score: 0.010
  82. Modified Magnesium Hydroxide Nanoparticles Inhibit the Inflammatory Response to Biodegradable Poly(lactide- co-glycolide) Implants. ACS Nano. 2018 07 24; 12(7):6917-6925.
    View in: PubMed
    Score: 0.010
  83. A sensitivity study of the key parameters in the interfacial photopolymerization of poly(ethylene glycol) diacrylate upon porcine islets. Biotechnol Bioeng. 1998 Mar 20; 57(6):655-65.
    View in: PubMed
    Score: 0.010
  84. Self-assembly and steric stabilization at heterogeneous, biological surfaces using adsorbing block copolymers. Chem Biol. 1998 Mar; 5(3):177-83.
    View in: PubMed
    Score: 0.010
  85. Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol. Am J Transplant. 2018 03; 18(3):590-603.
    View in: PubMed
    Score: 0.009
  86. Microfluidic production of bioactive fibrin micro-beads embedded in crosslinked collagen used as an injectable bulking agent for urinary incontinence treatment. Acta Biomater. 2018 02; 67:156-166.
    View in: PubMed
    Score: 0.009
  87. Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events. Sci Transl Med. 2017 Nov 08; 9(415).
    View in: PubMed
    Score: 0.009
  88. Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein. Virology. 2017 12; 512:161-171.
    View in: PubMed
    Score: 0.009
  89. Bioengineering strategies for inducing tolerance in autoimmune diabetes. Adv Drug Deliv Rev. 2017 05 15; 114:256-265.
    View in: PubMed
    Score: 0.009
  90. Advances in pancreatic islet monolayer culture on glass surfaces enable super-resolution microscopy and insights into beta cell ciliogenesis and proliferation. Sci Rep. 2017 04 12; 7:45961.
    View in: PubMed
    Score: 0.009
  91. Vaccine nanocarriers: Coupling intracellular pathways and cellular biodistribution to control CD4 vs CD8 T cell responses. Biomaterials. 2017 07; 132:48-58.
    View in: PubMed
    Score: 0.009
  92. Local induction of lymphangiogenesis with engineered fibrin-binding VEGF-C promotes wound healing by increasing immune cell trafficking and matrix remodeling. Biomaterials. 2017 07; 131:160-175.
    View in: PubMed
    Score: 0.009
  93. Primary Human and Rat ß-Cells Release the Intracellular Autoantigens GAD65, IA-2, and Proinsulin in Exosomes Together With Cytokine-Induced Enhancers of Immunity. Diabetes. 2017 02; 66(2):460-473.
    View in: PubMed
    Score: 0.009
  94. Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: the roles of medial and luminal factors in arterial healing. Proc Natl Acad Sci U S A. 1996 Nov 12; 93(23):13188-93.
    View in: PubMed
    Score: 0.009
  95. Engineered acellular collagen scaffold for endogenous cell guidance, a novel approach in urethral regeneration. Acta Biomater. 2016 10 01; 43:208-217.
    View in: PubMed
    Score: 0.008
  96. Aberrant Accumulation of the Diabetes Autoantigen GAD65 in Golgi Membranes in Conditions of ER Stress and Autoimmunity. Diabetes. 2016 09; 65(9):2686-99.
    View in: PubMed
    Score: 0.008
  97. IGF-1-containing multi-layered collagen-fibrin hybrid scaffolds for bladder tissue engineering. Acta Biomater. 2016 09 01; 41:75-85.
    View in: PubMed
    Score: 0.008
  98. Efficacy of adhesion barriers. Resorbable hydrogel, oxidized regenerated cellulose and hyaluronic acid. J Reprod Med. 1996 Mar; 41(3):149-54.
    View in: PubMed
    Score: 0.008
  99. Adhesion prevention with ancrod released via a tissue-adherent hydrogel. J Surg Res. 1996 Feb 15; 61(1):58-64.
    View in: PubMed
    Score: 0.008
  100. Effects of fibinolysis on neurite growth from dorsal root ganglia cultured in two- and three-dimensional fibrin gels. J Comp Neurol. 1996 Feb 12; 365(3):380-91.
    View in: PubMed
    Score: 0.008
  101. Local release of fibrinolytic agents for adhesion prevention. J Surg Res. 1995 Dec; 59(6):759-63.
    View in: PubMed
    Score: 0.008
  102. Comparison of covalently and physically cross-linked polyethylene glycol-based hydrogels for the prevention of postoperative adhesions in a rat model. Biomaterials. 1995 Oct; 16(15):1153-6.
    View in: PubMed
    Score: 0.008
  103. Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice. Sci Rep. 2015 Sep 21; 5:14274.
    View in: PubMed
    Score: 0.008
  104. Tubular Compressed Collagen Scaffolds for Ureteral Tissue Engineering in a Flow Bioreactor System. Tissue Eng Part A. 2015 Sep; 21(17-18):2334-45.
    View in: PubMed
    Score: 0.008
  105. Fibrin gels engineered with pro-angiogenic growth factors promote engraftment of pancreatic islets in extrahepatic sites in mice. Biotechnol Bioeng. 2015 Sep; 112(9):1916-26.
    View in: PubMed
    Score: 0.008
  106. 6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice. Cancer Immunol Immunother. 2015 Aug; 64(8):1033-46.
    View in: PubMed
    Score: 0.008
  107. Photo-crosslinked copolymers of 2-hydroxyethyl methacrylate, poly(ethylene glycol) tetra-acrylate and ethylene dimethacrylate for improving biocompatibility of biosensors. Biomaterials. 1995 Mar; 16(5):389-96.
    View in: PubMed
    Score: 0.008
  108. Molecular weight dependence of calcification of polyethylene glycol hydrogels. Biomaterials. 1994 Sep; 15(11):921-5.
    View in: PubMed
    Score: 0.007
  109. Efficacy of a resorbable hydrogel barrier, oxidized regenerated cellulose, and hyaluronic acid in the prevention of ovarian adhesions in a rabbit model. Fertil Steril. 1994 Sep; 62(3):630-4.
    View in: PubMed
    Score: 0.007
  110. Optimization of photopolymerized bioerodible hydrogel properties for adhesion prevention. J Biomed Mater Res. 1994 Jul; 28(7):831-8.
    View in: PubMed
    Score: 0.007
  111. Inhibition of thrombosis and intimal thickening by in situ photopolymerization of thin hydrogel barriers. Proc Natl Acad Sci U S A. 1994 Jun 21; 91(13):5967-71.
    View in: PubMed
    Score: 0.007
  112. Bioluminescent and micro-computed tomography imaging of bone repair induced by fibrin-binding growth factors. Acta Biomater. 2014 Oct; 10(10):4377-89.
    View in: PubMed
    Score: 0.007
  113. Clonal, self-renewing and differentiating human and porcine urothelial cells, a novel stem cell population. PLoS One. 2014; 9(2):e90006.
    View in: PubMed
    Score: 0.007
  114. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science. 2014 Feb 21; 343(6173):885-8.
    View in: PubMed
    Score: 0.007
  115. Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes. Cancer Immunol Res. 2014 May; 2(5):436-47.
    View in: PubMed
    Score: 0.007
  116. Culture of preantral follicles in poly(ethylene) glycol-based, three-dimensional hydrogel: a relationship between swelling ratio and follicular developments. J Tissue Eng Regen Med. 2015 Mar; 9(3):319-23.
    View in: PubMed
    Score: 0.007
  117. Prevention of postoperative adhesions in the rat by in situ photopolymerization of bioresorbable hydrogel barriers. Obstet Gynecol. 1994 Jan; 83(1):59-64.
    View in: PubMed
    Score: 0.007
  118. Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose. Proc Natl Acad Sci U S A. 2013 Dec 03; 110(49):19902-7.
    View in: PubMed
    Score: 0.007
  119. Fibronectin binding modulates CXCL11 activity and facilitates wound healing. PLoS One. 2013; 8(10):e79610.
    View in: PubMed
    Score: 0.007
  120. Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response. Biomaterials. 2014 Jan; 35(2):814-24.
    View in: PubMed
    Score: 0.007
  121. In situ cell manipulation through enzymatic hydrogel photopatterning. Nat Mater. 2013 Nov; 12(11):1072-8.
    View in: PubMed
    Score: 0.007
  122. Interfacial photopolymerization of poly(ethylene glycol)-based hydrogels upon alginate-poly(l-lysine) microcapsules for enhanced biocompatibility. Biomaterials. 1993 Oct; 14(13):1008-16.
    View in: PubMed
    Score: 0.007
  123. VEGFR-3 neutralization inhibits ovarian lymphangiogenesis, follicle maturation, and murine pregnancy. Am J Pathol. 2013 Nov; 183(5):1596-1607.
    View in: PubMed
    Score: 0.007
  124. Preparation of well-defined ibuprofen prodrug micelles by RAFT polymerization. Biomacromolecules. 2013 Sep 09; 14(9):3314-20.
    View in: PubMed
    Score: 0.007
  125. Proangiogenic hydrogels within macroporous scaffolds enhance islet engraftment in an extrahepatic site. Tissue Eng Part A. 2013 Dec; 19(23-24):2544-52.
    View in: PubMed
    Score: 0.007
  126. The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165. Biomaterials. 2013 Aug; 34(24):5958-68.
    View in: PubMed
    Score: 0.007
  127. Proteolytic processing regulates placental growth factor activities. J Biol Chem. 2013 Jun 21; 288(25):17976-89.
    View in: PubMed
    Score: 0.007
  128. Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice. PLoS One. 2013; 8(4):e61646.
    View in: PubMed
    Score: 0.007
  129. Covalently immobilized laminin peptide Tyr-Ile-Gly-Ser-Arg (YIGSR) supports cell spreading and co-localization of the 67-kilodalton laminin receptor with alpha-actinin and vinculin. J Biol Chem. 1993 Apr 15; 268(11):8053-9.
    View in: PubMed
    Score: 0.007
  130. Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles. Biomaterials. 2013 Jun; 34(17):4339-46.
    View in: PubMed
    Score: 0.007
  131. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci U S A. 2013 Mar 19; 110(12):4563-8.
    View in: PubMed
    Score: 0.007
  132. A high-throughput nanoimmunoassay chip applied to large-scale vaccine adjuvant screening. Integr Biol (Camb). 2013 Apr; 5(4):650-8.
    View in: PubMed
    Score: 0.007
  133. Engineering antigens for in situ erythrocyte binding induces T-cell deletion. Proc Natl Acad Sci U S A. 2013 Jan 02; 110(1):E60-8.
    View in: PubMed
    Score: 0.007
  134. Sorting live stem cells based on Sox2 mRNA expression. PLoS One. 2012; 7(11):e49874.
    View in: PubMed
    Score: 0.007
  135. Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization. Vaccine. 2012 Dec 14; 30(52):7541-6.
    View in: PubMed
    Score: 0.007
  136. Improving the osteogenic potential of BMP-2 with hyaluronic acid hydrogel modified with integrin-specific fibronectin fragment. Biomaterials. 2013 Jan; 34(3):704-12.
    View in: PubMed
    Score: 0.007
  137. Long-term maintenance of mouse embryonic stem cell pluripotency by manipulating integrin signaling within 3D scaffolds without active Stat3. Biomaterials. 2012 Dec; 33(35):8934-42.
    View in: PubMed
    Score: 0.007
  138. Engineering the regenerative microenvironment with biomaterials. Adv Healthc Mater. 2013 Jan; 2(1):57-71.
    View in: PubMed
    Score: 0.006
  139. Engineering approaches to immunotherapy. Sci Transl Med. 2012 Aug 22; 4(148):148rv9.
    View in: PubMed
    Score: 0.006
  140. In-vivo performance of high-density collagen gel tubes for urethral regeneration in a rabbit model. Biomaterials. 2012 Oct; 33(30):7447-55.
    View in: PubMed
    Score: 0.006
  141. Polymer micelles with pyridyl disulfide-coupled antigen travel through lymphatics and show enhanced cellular responses following immunization. Acta Biomater. 2012 Sep; 8(9):3210-7.
    View in: PubMed
    Score: 0.006
  142. Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes. Biomaterials. 2012 Sep; 33(26):6211-9.
    View in: PubMed
    Score: 0.006
  143. Embryonic stem cell-based cardiopatches improve cardiac function in infarcted rats. Stem Cells Transl Med. 2012 Mar; 1(3):248-60.
    View in: PubMed
    Score: 0.006
  144. Twenty-third annual Pezcoller Symposium: engineering influences in cancer research. Cancer Res. 2012 Feb 15; 72(4):841-4.
    View in: PubMed
    Score: 0.006
  145. Tissue response to intraperitoneal implants of polyethylene oxide-modified polyethylene terephthalate. Biomaterials. 1992; 13(8):505-10.
    View in: PubMed
    Score: 0.006
  146. Poly(ethylene oxide)-graft-poly(L-lysine) copolymers to enhance the biocompatibility of poly(L-lysine)-alginate microcapsule membranes. Biomaterials. 1992; 13(12):863-70.
    View in: PubMed
    Score: 0.006
  147. Engineered insulin-like growth factor-1 for improved smooth muscle regeneration. Biomaterials. 2012 Jan; 33(2):494-503.
    View in: PubMed
    Score: 0.006
  148. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci U S A. 2011 Nov 01; 108(44):E989-97.
    View in: PubMed
    Score: 0.006
  149. PEG-b-PPS-b-PEI micelles and PEG-b-PPS/PEG-b-PPS-b-PEI mixed micelles as non-viral vectors for plasmid DNA: tumor immunotoxicity in B16F10 melanoma. Biomaterials. 2011 Dec; 32(36):9839-47.
    View in: PubMed
    Score: 0.006
  150. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci Transl Med. 2011 Sep 14; 3(100):100ra89.
    View in: PubMed
    Score: 0.006
  151. Toxicity and exposure of an adenovirus containing human interferon alpha-2b following intracystic administration in cynomolgus monkeys. Gene Ther. 2012 Jul; 19(7):742-51.
    View in: PubMed
    Score: 0.006
  152. Nano-sized drug-loaded micelles deliver payload to lymph node immune cells and prolong allograft survival. J Control Release. 2011 Dec 10; 156(2):154-60.
    View in: PubMed
    Score: 0.006
  153. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Vaccine. 2011 Sep 16; 29(40):6959-66.
    View in: PubMed
    Score: 0.006
  154. A collagen-poly(lactic acid-co-?-caprolactone) hybrid scaffold for bladder tissue regeneration. Biomaterials. 2011 Jun; 32(16):3969-76.
    View in: PubMed
    Score: 0.006
  155. Engineering complement activation on polypropylene sulfide vaccine nanoparticles. Biomaterials. 2011 Mar; 32(8):2194-203.
    View in: PubMed
    Score: 0.006
  156. PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration. Vaccine. 2011 Jan 17; 29(4):804-12.
    View in: PubMed
    Score: 0.006
  157. Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials. 2011 Feb; 32(4):1102-9.
    View in: PubMed
    Score: 0.006
  158. Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation. Vaccine. 2010 Nov 23; 28(50):7897-906.
    View in: PubMed
    Score: 0.006
  159. Engineered aprotinin for improved stability of fibrin biomaterials. Biomaterials. 2011 Jan; 32(2):430-8.
    View in: PubMed
    Score: 0.006
  160. Biomimetic PEG hydrogels crosslinked with minimal plasmin-sensitive tri-amino acid peptides. J Biomed Mater Res A. 2010 Jun 01; 93(3):870-7.
    View in: PubMed
    Score: 0.006
  161. Controlled release nanoparticle-embedded coatings reduce the tissue reaction to neuroprostheses. J Control Release. 2010 Aug 03; 145(3):196-202.
    View in: PubMed
    Score: 0.006
  162. In vivo study of an injectable poly(acrylonitrile)-based hydrogel paste as a bulking agent for the treatment of urinary incontinence. Biomaterials. 2010 Jun; 31(17):4613-9.
    View in: PubMed
    Score: 0.005
  163. Compressed collagen gel: a novel scaffold for human bladder cells. J Tissue Eng Regen Med. 2010 Feb; 4(2):123-30.
    View in: PubMed
    Score: 0.005
  164. A facile strategy for the modification of polyethylene substrates with non-fouling, bioactive poly(poly(ethylene glycol) methacrylate) brushes. Macromol Biosci. 2010 Jan 11; 10(1):101-8.
    View in: PubMed
    Score: 0.005
  165. Covalently attached GRGD on polymer surfaces promotes biospecific adhesion of mammalian cells. Ann N Y Acad Sci. 1990; 589:261-70.
    View in: PubMed
    Score: 0.005
  166. Engineering integrin signaling for promoting embryonic stem cell self-renewal in a precisely defined niche. Biomaterials. 2010 Feb; 31(6):1219-26.
    View in: PubMed
    Score: 0.005
  167. A novel method for the encapsulation of biomolecules into polymersomes via direct hydration. Langmuir. 2009 Aug 18; 25(16):9025-9.
    View in: PubMed
    Score: 0.005
  168. Extracellular matrix binding mixed micelles for drug delivery applications. J Control Release. 2009 Jul 20; 137(2):146-51.
    View in: PubMed
    Score: 0.005
  169. Bone healing induced by local delivery of an engineered parathyroid hormone prodrug. Biomaterials. 2009 Mar; 30(9):1763-71.
    View in: PubMed
    Score: 0.005
  170. Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. Biomaterials. 2009 Feb; 30(6):1089-97.
    View in: PubMed
    Score: 0.005
  171. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel. Biomaterials. 2008 Jun; 29(18):2757-66.
    View in: PubMed
    Score: 0.005
  172. Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage. Nat Mater. 2008 Mar; 7(3):248-54.
    View in: PubMed
    Score: 0.005
  173. The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials. 2008 Apr; 29(11):1720-9.
    View in: PubMed
    Score: 0.005
  174. Bioluminescence imaging of calvarial bone repair using bone marrow and adipose tissue-derived mesenchymal stem cells. Biomaterials. 2008 Feb; 29(4):427-37.
    View in: PubMed
    Score: 0.005
  175. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol. 2007 Oct; 25(10):1159-64.
    View in: PubMed
    Score: 0.005
  176. RNA interference targeting hypoxia inducible factor 1alpha reduces post-operative adhesions in rats. J Surg Res. 2007 Aug; 141(2):162-70.
    View in: PubMed
    Score: 0.005
  177. PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery. Biomacromolecules. 2007 Jun; 8(6):1966-72.
    View in: PubMed
    Score: 0.004
  178. Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model. J Thorac Cardiovasc Surg. 2007 May; 133(5):1163-70.
    View in: PubMed
    Score: 0.004
  179. Analysis of progenitor cell-scaffold combinations by in vivo non-invasive photonic imaging. Biomaterials. 2007 Jun; 28(17):2718-28.
    View in: PubMed
    Score: 0.004
  180. Controlled release drug coatings on flexible neural probes. Annu Int Conf IEEE Eng Med Biol Soc. 2007; 2007:6613-6.
    View in: PubMed
    Score: 0.004
  181. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. Biomacromolecules. 2006 Nov; 7(11):3019-29.
    View in: PubMed
    Score: 0.004
  182. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol. 2006 Dec; 27(12):573-9.
    View in: PubMed
    Score: 0.004
  183. Polymer stent coating for prevention of neointimal hyperplasia. J Invasive Cardiol. 2006 Sep; 18(9):423-6; discussion 427.
    View in: PubMed
    Score: 0.004
  184. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release. 2006 May 01; 112(1):26-34.
    View in: PubMed
    Score: 0.004
  185. Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc Natl Acad Sci U S A. 2006 Feb 21; 103(8):2506-11.
    View in: PubMed
    Score: 0.004
  186. Pattern stability under cell culture conditions--a comparative study of patterning methods based on PLL-g-PEG background passivation. Biomaterials. 2006 Apr; 27(12):2534-41.
    View in: PubMed
    Score: 0.004
  187. PPS-PEG surface coating to reduce thrombogenicity of small diameter ePTFE vascular grafts. Int J Artif Organs. 2005 Oct; 28(10):993-1002.
    View in: PubMed
    Score: 0.004
  188. 3D morphology of cell cultures: a quantitative approach using micrometer synchrotron light tomography. Microsc Res Tech. 2005 Apr 15; 66(6):289-98.
    View in: PubMed
    Score: 0.004
  189. Neurite extension and in vitro myelination within three-dimensional modified fibrin matrices. J Neurobiol. 2005 Apr; 63(1):1-14.
    View in: PubMed
    Score: 0.004
  190. Effects of protein and gene transfer of the angiopoietin-1 fibrinogen-like receptor-binding domain on endothelial and vessel organization. J Biol Chem. 2005 Jun 10; 280(23):22445-53.
    View in: PubMed
    Score: 0.004
  191. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol Bioeng. 2005 Feb 05; 89(3):253-62.
    View in: PubMed
    Score: 0.004
  192. Poly (4-vinylimidazole) as nonviral gene carrier: in vitro and in vivo transfection. Acta Biomater. 2005 Mar; 1(2):165-72.
    View in: PubMed
    Score: 0.004
  193. Non-viral gene delivery for local and controlled DNA release. J Control Release. 2005 Jan 20; 102(1):263-75.
    View in: PubMed
    Score: 0.004
  194. Towards a fully synthetic substitute of alginate: optimization of a thermal gelation/chemical cross-linking scheme ("tandem" gelation) for the production of beads and liquid-core capsules. Biotechnol Bioeng. 2004 Dec 20; 88(6):740-9.
    View in: PubMed
    Score: 0.004
  195. Synthetic extracellular matrices for in situ tissue engineering. Biotechnol Bioeng. 2004 Apr 05; 86(1):27-36.
    View in: PubMed
    Score: 0.004
  196. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res. 2004 Apr 30; 94(8):1124-32.
    View in: PubMed
    Score: 0.004
  197. Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices. J Orthop Res. 2004 Mar; 22(2):376-81.
    View in: PubMed
    Score: 0.004
  198. Treatment of nonunions with nonglycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix. Vet Surg. 2004 Mar-Apr; 33(2):112-8.
    View in: PubMed
    Score: 0.004
  199. Bovine primary chondrocyte culture in synthetic matrix metalloproteinase-sensitive poly(ethylene glycol)-based hydrogels as a scaffold for cartilage repair. Tissue Eng. 2004 Mar-Apr; 10(3-4):515-22.
    View in: PubMed
    Score: 0.004
  200. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J. 2003 Dec; 17(15):2260-2.
    View in: PubMed
    Score: 0.004
  201. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol. 2003 May; 21(5):513-8.
    View in: PubMed
    Score: 0.003
  202. Pharmacokinetics, pharmacodynamics, and analgesic effects of morphine after rectal, intramuscular, and intravenous administration in dogs. Am J Vet Res. 2000 Jan; 61(1):24-8.
    View in: PubMed
    Score: 0.003
  203. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant. 1999 May-Jun; 8(3):293-306.
    View in: PubMed
    Score: 0.003
  204. Rapid induction of functional and morphological continuity between severed ends of mammalian or earthworm myelinated axons. J Neurosci. 1999 Apr 01; 19(7):2442-54.
    View in: PubMed
    Score: 0.003
  205. Effects of fibrin micromorphology on neurite growth from dorsal root ganglia cultured in three-dimensional fibrin gels. J Biomed Mater Res. 1998 Jun 15; 40(4):551-9.
    View in: PubMed
    Score: 0.002
  206. Immunoisolation of adult porcine islets for the treatment of diabetes mellitus. The use of photopolymerizable polyethylene glycol in the conformal coating of mass-isolated porcine islets. Ann N Y Acad Sci. 1997 Dec 31; 831:332-43.
    View in: PubMed
    Score: 0.002
  207. Design, characterization, and one-point in vivo calibration of a subcutaneously implanted glucose electrode. Anal Chem. 1994 Oct 01; 66(19):3131-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.